Abstract
Microscopic polyangiitis (MPA) is a systemic necrotizing vasculitis characterised by inflammation of the small blood vessels, the absence of granulommas on histopathological specimens, with few or no immune deposits and the presence of circulating anti-neutrophil cytoplasmic antibodies (ANCAs). The classic pulmonary manifestation is diffuse alveolar haemorrhage (DAH), but its association with pulmonary fibrosis (PF) has been increasingly reported and may be the first manifestation of MPA. Our aim was to evaluate MPA patients with PF and compare their characteristics and evolution to those of MPA patients without PF. We conducted a retrospective review of MPA patients followed in our hospital over a 15-year period. They were divided into two subgroups, with PF (MPA-PF) and without PF (MPA-non PF), and their clinical and functional features were compared. Nine of the 28 patients were classified as MPA-PF (32 %). This subgroup showed significantly more respiratory symptoms and higher mortality than MPA-non PF subgroup. The most frequent chest computed tomographic pattern of PF was usual interstitial pneumonia. PF preceded other manifestations of vasculitis in five patients and occurred simultaneously in the remaining four. During the follow-up period, four deaths were reported in the MPA-PF subgroup. No deaths were registered in the MPA-non PF subgroup. We found a high prevalence of MPA-PF patients (32 %), most of whom had a poor outcome and PF was often the first manifestation of the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Radice A, Sinici RA (2005) Antineutrophil cytoplasmic antibodies [ANCA]. Autoimmunity 38(1):93–103
Gomez-Puerta J, Hernandez-Rodriguez J, Lopez-Soto A, Xavier Bosch X (2009) Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest 136:1101–1
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC et al (2013) 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11
Chung S, Seo P (2010) Microscopic polyangiitis. Rheum Dis Clin N Am 36(3):545–558
Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA et al (2010) Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 36:116–121
Homma S, Matsushita H, Nakata K (2004) Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology 9(2):190–196
Hervier B, Pagnoux C, Agard C, Haroche J, Amoura Z et al (2009) French vasculitis study group. Pulmonary fibrosis associated with ANCA positive vasculitides: retrospective study of 12 cases and review of the literature. Ann Rheum Dis 68(3):404–407
Foulon G, Delaval P, Valeyre D, Wallaert B, Debray MP et al (2008) ANCA associated lung fibrosis: analysis of 17 patients. Respir Med 102(10):1392–1398
Nozu T, Kondo M, Suzuki K, Tamaoki J, Nagai A (2009) A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients. Respiration 77(4):407–415
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J et al (1994) Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 37:187–192
Watts R, Lane S, Hanslik T, Hauser T, Hellmich B et al (2007) Development and validation of a consensus methodology for the classification of the ANCA associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227
Smith RM, Jones RB, Jayne DRW (2012) Progress in treatment of ANCA-associated vasculitis. Arthritis Res Ther 14:210–228
Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42(3):421–430
Lauque D, Cadranel J, Lazor R, Pourrat J, Ronco P et al (2000) Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines"Pulmonaires[GERM"O"P]. Medicine (Baltimore) 79(4):222–233
Collins CE, Quismorio FP Jr (2005) Pulmonary involvement in microscopic polyangiitis. Curr Opin Pulm Med 11(5):447–451
Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE (1990) Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 65(6):847–856
Eschun GM, Mink SN, Sharma S (2003) Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 123(1):297–301
Eleftheriou D, Katsenos S, Zorbas S, Griveas I, Psathakis K (2012) Pulmonary fibrosis presenting as an early manifestation of microscopic polyangiitis. Monaldi Arch Chest Dis 77(3–4):141–144
Tanaka T, Otani K, Egashira R, Kashima Y, Taniguchi H et al (2012) Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients. Respir Med 106:1765–1770
Fernández Casares M, Gonzalez A, Caputo F, Bottinelli Y, Nastavi P et al (2012) Pulmonary fibrosis associated with anti-neutrophil cytoplasmic antibody positive vasculitis. Medicina (Buenos Aires) 72:329–331
Yamada H (2011) ANCA-associated lung fibrosis. Semin Respir Crit Care Med 32:322–327
Gaudin PB, Askin FB, Falk RJ, Jennette JC (1995) The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 104(1):7–16
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernandez Casares, M., Gonzalez, A., Fielli, M. et al. Microscopic polyangiitis associated with pulmonary fibrosis. Clin Rheumatol 34, 1273–1277 (2015). https://doi.org/10.1007/s10067-014-2676-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2676-1